ArticleScientific reports2017

Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity.

Divya Sagar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.